Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Managed Care (Langhorne, Pa.)
|
October 30, 2013
Employers need to better understand the costs of specialty pharmacy
F Randy Vogenberg, Cheryl Larson, Margaret Rehayem, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 19, 2012
Biologics and specialty pharmacy health care survey: implications for p&t committees
Cheryl Larson, Margaret Rehayem, F Randy Vogenberg, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 4, 2013
The affordable care act: new features in 2013
E Paul Larrat, Rita M Marcoux, F Randy Vogenberg
Managed Care (Langhorne, Pa.)
|
April 5, 2012
Employers mostly in the dark when it comes to biologics
Cheryl Larson, Margaret Rehayem, Boress Larry, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 14, 2019
Regulatory and Legislative Disparities With Cannabis Present Challenges to P&T Committees and Health Care Providers
Rita Marcoux, Lauren Holmes, F Randy Vogenberg, et al.
American Health & Drug Benefits
|
July 4, 2014
Beyond the cost of biologics: employer survey reveals gap in understanding role of specialty pharmacy and benefit design
F Randy Vogenberg, Cheryl Larson, Margaret Rehayem, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
January 7, 2014
Medical marijuana and related legal aspects
Rita M Marcoux, E Paul Larrat, F Randy Vogenberg
Healthcare Financial Management : Journal of the Healthcare Financial Management Association
|
August 10, 2004
Balancing physician and cost-containment demands
F Randy Vogenberg, Leo K Lichtig, Richard M Weinberg, et al.
American Journal of Orthopedics (Belle Mead, N.J.)
|
May 23, 2007
Factors associated with thromboprophylaxis for orthopedic patients and their impact on outcome
James E Muntz, Paul J O'Connor, Hongjun Yin, et al.
Pharmacoeconomics
|
November 1, 2016
A Review of US Drug Costs Relevant to Medicare, Medicaid, and Commercial Insurers Post-Affordable Care Act Enactment, 2010-2016
Jacquelyn McRae, F Randy Vogenberg, Silky Webb Beaty, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Managed Care (Langhorne, Pa.)
|
October 30, 2013
Employers need to better understand the costs of specialty pharmacy
F Randy Vogenberg, Cheryl Larson, Margaret Rehayem, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 19, 2012
Biologics and specialty pharmacy health care survey: implications for p&t committees
Cheryl Larson, Margaret Rehayem, F Randy Vogenberg, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 4, 2013
The affordable care act: new features in 2013
E Paul Larrat, Rita M Marcoux, F Randy Vogenberg
Managed Care (Langhorne, Pa.)
|
April 5, 2012
Employers mostly in the dark when it comes to biologics
Cheryl Larson, Margaret Rehayem, Boress Larry, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 14, 2019
Regulatory and Legislative Disparities With Cannabis Present Challenges to P&T Committees and Health Care Providers
Rita Marcoux, Lauren Holmes, F Randy Vogenberg, et al.
American Health & Drug Benefits
|
July 4, 2014
Beyond the cost of biologics: employer survey reveals gap in understanding role of specialty pharmacy and benefit design
F Randy Vogenberg, Cheryl Larson, Margaret Rehayem, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
January 7, 2014
Medical marijuana and related legal aspects
Rita M Marcoux, E Paul Larrat, F Randy Vogenberg
Healthcare Financial Management : Journal of the Healthcare Financial Management Association
|
August 10, 2004
Balancing physician and cost-containment demands
F Randy Vogenberg, Leo K Lichtig, Richard M Weinberg, et al.
American Journal of Orthopedics (Belle Mead, N.J.)
|
May 23, 2007
Factors associated with thromboprophylaxis for orthopedic patients and their impact on outcome
James E Muntz, Paul J O'Connor, Hongjun Yin, et al.
Pharmacoeconomics
|
November 1, 2016
A Review of US Drug Costs Relevant to Medicare, Medicaid, and Commercial Insurers Post-Affordable Care Act Enactment, 2010-2016
Jacquelyn McRae, F Randy Vogenberg, Silky Webb Beaty, et al.
Page
of 9